Evidence map›Paper›PMID 38090089›Full record

ArticleRSC advances2023

Investigation of

Frizka Vietanti, Tzu-An Lee, Hsiu-Yang Tseng, Yu-Jen Chou

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. SrO-Containing Bioactive Glasses in the SiOACS biomaterials science & engineering · 2025
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Frizka VietantiDepartment of Mechanical Engineering, National Taiwan University of Science and Technology No. 43, Sec. 4, Keelung Road Taipei 10607 Taiwan yu-jen.chou@mail.ntust.edu.tw +886-2-2737-6492.
Tzu-An LeeDepartment of Mechanical Engineering, National Taiwan University of Science and Technology No. 43, Sec. 4, Keelung Road Taipei 10607 Taiwan yu-jen.chou@mail.ntust.edu.tw +886-2-2737-6492.
Hsiu-Yang TsengDepartment of Mechanical Engineering, National Taiwan University of Science and Technology No. 43, Sec. 4, Keelung Road Taipei 10607 Taiwan yu-jen.chou@mail.ntust.edu.tw +886-2-2737-6492.
Yu-Jen ChouDepartment of Mechanical Engineering, National Taiwan University of Science and Technology No. 43, Sec. 4, Keelung Road Taipei 10607 Taiwan yu-jen.chou@mail.ntust.edu.tw +886-2-2737-6492.ORCID https://orcid.org/0000-0002-7135-4653
National Taiwan University of Science and Technology · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bioactive glass is a potential biomaterial for bone reconstruction owing to its superior bioactivity and non-toxicity. Yet, the absence of a circulatory system to carry waste and nutrients is a key issue with biomaterials implanted in the body. Thus the development of functional and vascularized new tissue requires the development of angiogenesis, which involves the formation of new blood vessels. Based on this perspective, we aimed to fabricate boron-doped 58S bioactive glass microspheres using the spray drying method, which could offer great flowability, controllable morphology, and narrow size distribution. Characterization of particle morphology and elemental composition were examined using scanning electron microscopy along with energy dispersive spectroscopy, respectively. To evaluate the effect of the boron dopant on

Identifiers

PMID38090089
PMCPMC10714135
OpenAlexW4389618793

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.